| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 7.164 | 1.054 | 23.267 | 49.542 | 46.708 |
| Total Income - EUR | - | - | - | - | - | 7.164 | 1.054 | 23.267 | 49.542 | 46.708 |
| Total Expenses - EUR | - | - | - | - | - | 3.939 | 243 | 4.720 | 9.641 | 11.413 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 3.225 | 811 | 18.548 | 39.901 | 35.296 |
| Net Profit/Loss - EUR | - | - | - | - | - | 3.138 | 780 | 17.864 | 39.415 | 33.923 |
| Employees | - | - | - | - | - | 1 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Neuro Diag S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | 3.301 | 859 | 19.271 | 49.923 | 58.498 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 28 | 0 | 9.125 | 3.374 | 22.656 |
| Cash | - | - | - | - | - | 3.273 | 859 | 10.146 | 46.549 | 35.842 |
| Shareholders Funds | - | - | - | - | - | 3.179 | 829 | 17.912 | 39.464 | 33.971 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 122 | 30 | 1.358 | 10.460 | 24.527 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neuro Diag S.r.l.